Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), among Patients Exposed to Non-Clostridioides Difficile Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label Study.
OPEN FORUM INFECTIOUS DISEASES（2024）
关键词
antibiotics,clinical trials,Clostridioides difficile infection,microbiota-based therapy,recurrence
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要